Brief: Chugai Files Lawsuit Against Alexion Alleging Infringement Of Its Proprietary Antibody Engineering Technology In U.S.
16/11/2018 02:34
Nov 16 (Reuters) - Chugai Pharmaceutical Co Ltd 4519.T :
* FILES LAWSUIT AGAINST ALEXION ALLEGING INFRINGEMENT OF ITS
PROPRIETARY ANTIBODY ENGINEERING TECHNOLOGY IN U.S.
Source text for Eikon: ID:nTSWP6b12c
Further company coverage: 4519.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)